Extended-Release Drugs Market Growth Trajectory, Key Drivers And Trends

The Business Research Company’s Extended-Release Drugs Global Market Report 2023 is the most detailed report available on the market, including broad forecast periods and multiple geographies. The report covers the historic period – 2010-2021, and the forecast period – 2023-2032. The Extended-Release Drugs Global Market Report 2023 evaluates extended-release drugs market size, growth rate, drivers, trends, and major companies.

The report provides a global perspective by covering 60 geographies and focusing on major economies in each region – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Free Sample Of The Report (Includes Graphs And Tables):

https://www.thebusinessresearchcompany.com/sample_request?id=12675&type=smp

The global extended-release drugs market is expected to grow from $51.06 billion in 2022 to $57.11 billion in 2023 at a compound annual growth rate (CAGR) of 11.9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic. The war between these two countries has led to economic sanctions on multiple countries, surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and resulted in increased interest rates affecting many markets across the globe. The extended-release drugs market is expected to reach $88.22 billion in 2027 at a CAGR of 11.5%.

The increasing incidence of chronic conditions is expected to propel the growth of the extended-release drug market going forward. Chronic conditions are defined as conditions that last for a year or longer and necessitate continuing medical care, restricting everyday activities, or both. Heart disease, cancer, obesity, and diabetes are a few examples. Extended-release drug delivery systems are designed to provide a relatively constant level of medication in the body over a long period. It helps maintain a consistent therapeutic effect and avoids the fluctuations in drug levels that can occur with immediate-release medications. For instance, in January 2023, according to the National Center for Biotechnology Information (NCBI), a US-based National Library of Medicine, it was projected that by the year 2050, the number of individuals aged 50 years and older who have at least one chronic illness will surge by 99.5%, rising from 71.522 million in 2020 to 142.66 million. Therefore, the increasing incidence of chronic conditions is driving the growth of the extended-release drug market.

Get More Information On The Extended-Release Drugs Market Report:

https://www.thebusinessresearchcompany.com/report/extended-release-drugs-global-market-report

The extended-release drugs market segments in the report are:

1) By Type: Sustained Release Drug, Controlled Release Drug

2) By Mode: Over-The-Counter, Prescription

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Mail Order Pharmacies, Drug Stores

The table of contents in TBRC’s extended-release drugs market report includes:

1. Executive Summary
2. Extended-Release Drugs Market Characteristics
3. Extended-Release Drugs Market Trends And Strategies
4. Extended-Release Drugs Market – Macro Economic Scenario

5.1. Global Extended-Release Drugs Market Drivers and Restraints

6. Extended-Release Drugs Market Segmentation
7. Extended-Release Drugs Market Regional And Country Analysis

.

.

.

27. Brazil Extended-Release Drugs Market
28. Middle East Extended-Release Drugs Market
29. Africa Extended-Release Drugs Market

Learn About Us:
The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.

Contact Us:
The Business Research Company
Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: info@tbrc.info

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Blog: https://blog.tbrc.info/

Healthcare Blog: https://healthcareresearchreports.com/

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model